These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38155038)

  • 1. Interleukin-33/serum stimulation-2 pathway: Regulatory mechanisms and emerging implications in immune and inflammatory diseases.
    He PY; Wu MY; Zheng LY; Duan Y; Fan Q; Zhu XM; Yao YM
    Cytokine Growth Factor Rev; 2024 Apr; 76():112-126. PubMed ID: 38155038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
    Chen WY; Tsai TH; Yang JL; Li LC
    Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions.
    Guo H; Bossila EA; Ma X; Zhao C; Zhao Y
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological effects of IL-33/ST2 axis on oral diseases: autoimmune diseases and periodontal diseases.
    Wang M; Gao M; Yi Z
    Int Immunopharmacol; 2023 Sep; 122():110524. PubMed ID: 37393839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the IL-33/ST2 axis in autoimmune disorders: Friend or foe?
    Liu X; Xiao Y; Pan Y; Li H; Zheng SG; Su W
    Cytokine Growth Factor Rev; 2019 Dec; 50():60-74. PubMed ID: 31085085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-33's role in the gut immune system: A comprehensive review of its crosstalk and regulation.
    Kaur H; Kaur G; Ali SA
    Life Sci; 2023 Aug; 327():121868. PubMed ID: 37330043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-33/ST2 Axis in Organ Fibrosis.
    Kotsiou OS; Gourgoulianis KI; Zarogiannis SG
    Front Immunol; 2018; 9():2432. PubMed ID: 30405626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-33 in autoimmunity; possible therapeutic target.
    Yuan C
    Int Immunopharmacol; 2022 Jul; 108():108887. PubMed ID: 35729828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-33/ST2 axis in inflammation and immunopathology.
    Milovanovic M; Volarevic V; Radosavljevic G; Jovanovic I; Pejnovic N; Arsenijevic N; Lukic ML
    Immunol Res; 2012 Apr; 52(1-2):89-99. PubMed ID: 22392053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-33/ST2 axis in autoimmune disease.
    Shakerian L; Kolahdooz H; Garousi M; Keyvani V; Kamal Kheder R; Abdulsattar Faraj T; Yazdanpanah E; Esmaeili SA
    Cytokine; 2022 Oct; 158():156015. PubMed ID: 36041312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of IL-33 and its receptor in T cell-mediated autoimmune diseases.
    Zhao Q; Chen G
    Biomed Res Int; 2014; 2014():587376. PubMed ID: 25032216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Neuroinflammation: Advances in Roles and Mechanisms of the IL-33/ST2 Axis Involved in Ischemic Stroke.
    Guo S; Qian C; Li W; Zeng Z; Cai J; Luo Y
    Neuroimmunomodulation; 2023; 30(1):226-236. PubMed ID: 37729881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-33/ST2 Axis: A Potential Therapeutic Target in Neurodegenerative Diseases.
    Jia Z; Guo M; Ge X; Chen F; Lei P
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
    Cayrol C; Girard JP
    Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanisms Underlying IL-33-Mediated Inflammation in Inflammatory Bowel Disease.
    Aggeletopoulou I; Tsounis EP; Triantos C
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.
    Pejnovic N; Jeftic I; Jovicic N; Arsenijevic N; Lukic ML
    World J Gastroenterol; 2016 Nov; 22(44):9706-9717. PubMed ID: 27956794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.
    Takatori H; Makita S; Ito T; Matsuki A; Nakajima H
    Front Immunol; 2018; 9():2004. PubMed ID: 30233590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-33/ST2 Pathway as a Rational Therapeutic Target for CNS Diseases.
    Du LX; Wang YQ; Hua GQ; Mi WL
    Neuroscience; 2018 Jan; 369():222-230. PubMed ID: 29175156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T
    Pascual-Reguant A; Bayat Sarmadi J; Baumann C; Noster R; Cirera-Salinas D; Curato C; Pelczar P; Huber S; Zielinski CE; Löhning M; Hauser AE; Esplugues E
    Mucosal Immunol; 2017 Nov; 10(6):1431-1442. PubMed ID: 28198366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Roles of IL-33/ST2 Axis in Renal Diseases.
    Chen WY; Li LC; Yang JL
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.